Comparison 11. combined regimen mifepristone/prostaglandin:single vs continuous prostaglandin.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 failure to achieve complete abortion	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
1.1 all oral vs vaginal & continuous oral	2	1581	Risk Ratio (M‐H, Fixed, 95% CI)	1.48 [1.01, 2.16]
1.2 all oral vs single vaginal	2	1578	Risk Ratio (M‐H, Fixed, 95% CI)	1.19 [0.83, 1.70]
1.3 vaginal & continuous oral vs single vaginal	2	1579	Risk Ratio (M‐H, Fixed, 95% CI)	0.80 [0.54, 1.19]
1.4 all oral vs vaginal & continuous oral </=49 days	1	476	Risk Ratio (M‐H, Fixed, 95% CI)	1.17 [0.57, 2.41]
1.5 all oral vs vaginal & continuous oral > 49 days	1	1004	Risk Ratio (M‐H, Fixed, 95% CI)	1.60 [1.00, 2.57]
1.6 all oral vs single vaginal >/=49 days	1	459	Risk Ratio (M‐H, Fixed, 95% CI)	1.29 [0.60, 2.74]
1.7 all oral vs single vaginal > 49 days	1	1014	Risk Ratio (M‐H, Fixed, 95% CI)	1.12 [0.73, 1.70]
1.8 vaginal & continuous oral vs single vaginal >/=49days	1	463	Risk Ratio (M‐H, Fixed, 95% CI)	1.10 [0.50, 2.40]
1.9 vaginal & continuous oral vs single vaginal > 49 days	1	1010	Risk Ratio (M‐H, Fixed, 95% CI)	0.70 [0.43, 1.13]
2 ongoing pregnancy at follow‐up	2		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 all oral vs vaginal & continuous oral	2		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.2 all oral vs single vaginal	2		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.3 vaginal & continuous oral vs single vaginal	2		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 nausea	1	4438	Risk Ratio (M‐H, Fixed, 95% CI)	0.96 [0.83, 1.12]
3.1 all oral vs vaginal & continuous oral	1	1481	Risk Ratio (M‐H, Fixed, 95% CI)	0.84 [0.65, 1.09]
3.2 all oral vs single vaginal	1	1478	Risk Ratio (M‐H, Fixed, 95% CI)	0.94 [0.72, 1.24]
3.3 vaginal & continuous oral vs single vaginal	1	1479	Risk Ratio (M‐H, Fixed, 95% CI)	1.12 [0.87, 1.45]
4 vomiting	1	4438	Risk Ratio (M‐H, Fixed, 95% CI)	0.92 [0.69, 1.21]
4.1 all oral vs vaginal & continuous oral	1	1481	Risk Ratio (M‐H, Fixed, 95% CI)	0.80 [0.49, 1.30]
4.2 all oral vs single vaginal	1	1478	Risk Ratio (M‐H, Fixed, 95% CI)	0.87 [0.53, 1.43]
4.3 vaginal & continuous oral vs single vaginal	1	1479	Risk Ratio (M‐H, Fixed, 95% CI)	1.09 [0.68, 1.74]
5 diarrhoea	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
5.1 all oral vs vaginal & continuous oral	1	1481	Risk Ratio (M‐H, Fixed, 95% CI)	1.83 [1.11, 3.01]
5.2 all oral vs single vaginal	1	1478	Risk Ratio (M‐H, Fixed, 95% CI)	2.09 [1.24, 3.53]
5.3 vaginal & continuous oral vs single vaginal	1	1479	Risk Ratio (M‐H, Fixed, 95% CI)	1.15 [0.63, 2.07]